Clinigen targets validated by SBTi, setting verified path to Net-Zero

Clinigen targets validated by SBTi, setting verified path to Net-Zero

LONDON, UK, 04 December 2025 - Clinigen, the global pathfinder accelerating access to critical medicines, has today announced that its near-term and long-term greenhouse gas (GHG) emission reduction targets have been validated by the Science Based Targets initiative (SBTi).

This validation confirms that Clinigen's roadmap to reduce scope 1, 2, and 3 emissions is scientifically aligned with the 1.5°C trajectory of the Paris Agreement.

The pharmaceutical industry faces a critical dual mandate of delivering increasingly complex, life-changing medicines to an aging global population, while urgently addressing its environmental footprint.

With the health sector responsible for approximately 4.4% of global GHG emissions, and recent data suggesting the pharmaceutical value chain has a higher carbon intensity than the automotive sector, decarbonising the clinical supply chain has become a critical factor in de-risking the product lifecycle.

Clinigen's validated science-based targets provides a verifiable pathway for biotech and pharma partners to decouple their clinical and commercial growth from carbon emissions.

Clinigen has aligned with the SBTi Corporate Net-Zero Standard with the goal of reaching net-zero GHG emissions across the value chain by 2040:

• By 2030, Clinigen will target a 42% reduction across scope 1, 2, and 3 emissions.

• By 2040, Clinigen will push for a 90% reduction across all scopes.

Clinigen is committed to improving data accuracy and transparency to better manage the reduction measures required to meet these targets. To achieve this, the company is partnering with Tracera, an AI-powered ESG data platform, and sustainability partners Seismic.

Together, they are developing a robust process to track emissions across global operations with greater accuracy, moving beyond reliance on standard industry estimates. The goal is to translate these climate targets into verifiable value for partners.

Varun Sethi, CEO of Clinigen, said: "As Global Pathfinders, our clients rely on us to navigate complexity, and climate risk is now a central part of that landscape. By validating our SBTi targets, we are ensuring that Clinigen is moving in lockstep with the biopharma industry's most ambitious sustainability goals. This validation confirms our roadmap is scientifically robust, but it is the actions we take next on this net-zero journey that matter. We are committed to aligning our operations with the climate goals and expectations of our clients, ensuring that Clinigen remains a resilient, responsible partner for the long term."

Andy Owen, Vice President of Supply Chain at Clinigen, said: "For our carbon-intensive industry, sustainability has to be a top priority, and we are more driven than ever to lead. This validation sets the direction of travel, but the destination is still a long way off. Net-zero is a complex journey, but one we are fully committed to navigating alongside our partners. Our focus now shifts to execution of our targeted initiatives and the industry partnerships needed to drive real reductions across our value chain."

-ENDS-

For media enquiries, please contact:

[email protected]

Notes to editors:

Targets validated by Science Based Targets initiative (SBTi). This public commitment outlines our ambitious goals to reduce our carbon emissions against our baseline year of FY2023:

• Scope 1, 2, and 3 emissions by 42% by 2030.
• Scope 1, 2, and 3 emissions by 90% by 2040.

Our baseline year figures:

• Scope 1 - 999 tCO2e (Carbon Tonnes)
• Scope 2 - 3,595 tCO2e (Carbon Tonnes)
• Scope 3 - 32,025 tCO2e (Carbon Tonnes)

To achieve these targets, we're planning key initiatives, including switching all our gas and electricity suppliers to green tariffs (clean energy) where possible. We'll prioritise engagement with our upstream and downstream transportation partners to encourage more sustainable distribution methods (like electric fleets) and transition our own internal fleet, such as forklifts, to electric power by 2040.

About Clinigen

Clinigen is a global pharmaceutical services company trusted by over 1,000 pharma and biotech partners. With more than 35 years of experience, we accelerate access to critical medicines at every stage of the product lifecycle. As pathfinders, our team of over 1,100 specialists expertly navigate the complexities of clinical trial supply, early access programs, regulatory services, and long-term commercialisation through both licensed and unlicensed pathways. Operating across five continents, we deliver innovative solutions to over 130 countries each year. Whatever the challenge, we find a way.

Explore our services at www.clinigen.com

About Seismic

Seismic is a full service sustainability partner where commercial results and positive impact grow together. We combine strategic guidance with hands-on delivery, working as an embedded sustainability team inside companies that want to move faster and with more confidence.

Our work spans strategy, climate, disclosure, communications, circularity and supply chain - helping businesses to prosper by becoming increasingly impactful and influential forces for good.

Visit www.seismic-change.com

About Tracera

Tracera, formerly ESG Flo, is redefining sustainability data management with its AI-powered platform that automates the collection, verification, and auditing of sustainability data. Focused on elevating sustainability data to finance-grade standards, Tracera empowers businesses to achieve seamless compliance and substantiate their sustainability claims with accurate, traceable data - paving the way for smarter, sustainable growth.

About the Science Based Targets initiative

The Science Based Targets initiative (SBTi) is a corporate climate action organization that enables companies and financial institutions worldwide to play their part in combating the climate crisis.

We develop standards, tools and guidance which allow companies to set greenhouse gas (GHG) emissions reductions targets in line with what is needed to keep global heating below catastrophic levels and reach net-zero by 2050 at latest.

The SBTi is incorporated as a charity, with a subsidiary which will host our target validation services. Our partners are CDP, the United Nations Global Compact, the We Mean Business Coalition, the World Resources Institute (WRI), and the World Wide Fund for Nature (WWF).

https://sciencebasedtargets.org/